Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2

Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2

US Patent 12479847 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2025
Potent and selective covalent inhibitors of serine-arginine protein kinase (SRPK2025
Potent and selective covalent inhibitors of serine-arginine protein kinase (SRPK2025
Degraders of cyclin-dependent kinase 7 (CDK7) and uses thereof2025
Carbonyl reductase, nucleic acid encoding same, and method for producing optical2025
CDK2/5 degraders and uses thereof2025
Display device2025
Display panel with a repair circuit2025
Method for managing user account using near-field communication in wireless comm2025
Method and device for scanning for and connecting bluetooth device2025
Plasticizer composition and vinylchloride resin composition comprising the same2025
Frame for crutches2025